Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in ProNAi Therapeutics, Inc. (NASDAQ: DNAI) Securities Case

Loading...
Loading...

NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) --  Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national investor rights law firm, reminds investors that January 9, 2017 is the last day to file lead plaintiff papers in the securities lawsuit against ProNAi Therapeutics, Inc. ("ProNAi" or the "Company") DNAI.  The class action is on behalf of a class consisting of all persons who purchased ProNAi common stock between July 15, 2015 and June 6, 2016, inclusive (the "Class Period").  ProNAi investors are encouraged to go to: http://www.scott-scott.com/cases/new/securities-fraud-litigation-3032-pronai-therapeutics-inc-dnai.html

ProNAi is a clinical stage oncology company with a focus on pioneering a novel class of therapeutics based on its proprietary DNA interference ("DNAi") technology platform.  Until recently, the Company had only one product candidate – PNT2258, which was purportedly designed to target cancers that overexpress B-cell lymphoma such as Hodgkin's lymphomas and non-Hodgkin lymphoma.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that the Wolverine and Brighton Phase 2 trials of PNT2258 would fail to prove the efficacy and safety of PNT2258 by meeting its primary or secondary endpoints.

On June 6, 2016, the Company issued a press release announcing interim data for the two Phase 2 trials and revealed that PNT2258 had failed to produce sufficient efficacy results to justify its continued clinical development.  On this news, the price of ProNAi common stock declined more than 67%.

What You Can Do

If you purchased ProNAi shares, you may have legal claims against the Company.  If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact attorney Joseph Pettigrew at (619) 517-1129, or at jpettigrew@scott-scott.com.

About Scott + Scott, Attorneys at Law, LLP

Scott+Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm has offices in New York, London, Connecticut, California, and Ohio.  Please visit www.scott-scott.com for more information about the firm.

CONTACT: Joseph Pettigrew Scott+Scott, Attorneys at Law, LLP (619) 517-1129 jpettigrew@scott-scott.com
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...